Aditxt, Inc.

ADTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024
Revenue $12.2K $425 $748 $1.0K $1.0K $3.2K $6.9K $44.3K
Cost of Revenue $9.3K $456 $732 $1.0K $734 $71.0K $467.5K $23.1K
Gross Profit $2.9K $-31 $16 $-1 $284 $-67.8K $-460.7K $21.1K
Gross Margin 23.6% -7.3% 2.1% -0.1% 27.9% -2,136.4% -6,721.4% 47.8%
Operating Expenses
Research & Development $1.0M $548.6K $672.0K $764.3K $1.2M $696.0K $491.6K $1.6M
SG&A Expense $3.3M $4.1M $2.5M $5.0M $4.3M $4.8M $3.7M $4.4M
Operating Income $-4.4M $-4.7M $-3.1M $-6.2M $-5.6M $-5.7M $-4.7M $-6.0M
Operating Margin -35,873.5% -1,098,725.6% -419,870.3% -612,788.3% -550,895.4% -177,985.3% -68,588.2% -13,497.1%
Interest Expense
Pretax Income $-16.2M $-5.2M $-24.2M $-7.4M $-6.0M $-5.5M $-7.0M $-7.6M
Income Tax Expense
Net Income $-15.9M $-6.1M $-24.0M $-7.3M $-5.7M $-5.2M $-12.8M $-7.5M
Net Margin -131,159.8% -1,432,689.2% -3,214,626.3% -722,789.6% -560,934.1% -164,618.2% -187,445.6% -17,051.3%
EPS (Basic) $-790.49 $197,471.38 $-182.93 $-1.15 $-66,024.33 $-6,305,744.47 $-1,045,898.40 $-349.06
EPS (Diluted) $-790.49 $197,471.38 $-182.93 $-1.15 $-66,024.33 $-6,305,744.47 $-1,045,898.40 $-349.06
Shares Outstanding (Basic) 20.2K 37.4K 131.4K 6.3M 2.1M 39.5K 347.0K 5.4M
Shares Outstanding (Diluted) 20.2K 37.4K 131.4K 6.3M 2.1M 39.5K 347.0K 5.4M
Dividends Per Share
← Newer Page 1 of 3 Older →